RedC Biotech

RedC Biotech
Developing universal donor-free red blood cells for life-saving transfusions and advanced therapies.
About
What does RedC Biotech do?
RedC Biotech produces proprietary, donor-free, universal red blood cells designed to be suitable for almost every patient. This technology aims to provide unlimited, high-quality, and low-cost blood transfusions for life-saving treatments and advanced therapies, addressing the global shortage and complex supply chain of traditional blood donations.
What is RedC Biotech's revenue?
StartupHub estimates RedC Biotech's annual revenue at $845K (range $476K to $1.3M, 64% confidence), based on comparable companies in the sector.
Where is RedC Biotech headquartered?
RedC Biotech is headquartered in San Diego, United States.
When was RedC Biotech founded?
RedC Biotech was founded in 2015.
What industry does RedC Biotech operate in?
RedC Biotech operates in Life Sciences, Biotech, Blood, HealthTech, Drug Discovery, Clinical Trials.
How many employees does RedC Biotech have?
RedC Biotech has approximately 5 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Biotalent is a platform that streamlines biotech hiring by connecting qualified candidates with job opportunities and providing hiring teams with tools for efficient candidate review.
AI-powered platform accelerating biological research and drug discovery.
A healthcare and life sciences consulting firm leveraging AI and data analytics for strategic solutions.
Empowering Life Science Entrepreneurs for Innovative Healthcare Solutions.
An entrant is a company tagged Life Sciences whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.
